"I am glad that taking part in a trial might help others on their own cancer journey.”
A study looking at buparlisib and radiotherapy for non small cell lung cancer
We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.
This study looked at a cancer growth blocker called buparlisib and radiotherapy for a type of lung cancer called non small cell lung cancer. It was supported by Cancer Research UK.
More about this trial
- the best dose of buparlisib to give alongside radiotherapy
- whether buparlisib can change the amount of oxygen getting to the cancer cells
- more about the side effects
Summary of results
- buparlisib tablets once a day for two weeks
- radiotherapy once a day for 5 days during the second week of buparlisib
- a PET-CT scan before treatment and a week after finishing treatment
- tiredness (fatigue)
- feeling sick
- a drop in appetite
How to join a clinical trial
Dr Geoff Higgins
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Oxford Cancer Imaging Centre
University of Oxford
This is Cancer Research UK trial number CRUKD/12/016.